Liv Vernstrøm

Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial

Søren Gullaksen, Liv Vernstrøm, Steffen S. Sørensen et al. · Diabetologia · 2023 · 58 citations · Full text

Metabolic Syndrome, Diabetes Management, Renal Function +11

Separate and combined effects of empagliflozin and semaglutide on vascular function: A 32‐week randomized trial

Liv Vernstrøm, Søren Gullaksen, Steffen S. Sørensen et al. · Diabetes Obesity and Metabolism · 2024 · 22 citations · Full text

Evaluation of renal oxygenation by BOLD–MRI in high-risk patients with type 2 diabetes and matched controls

Steffen S. Sørensen, Søren Gullaksen, Liv Vernstrøm et al. · Nephrology Dialysis Transplantation · 2022 · 15 citations

Antiplatelet effect of aspirin during 24 h in patients with type 2 diabetes without cardiovascular disease

Liv Vernstrøm, Kristian Løkke Funck, Erik Lerkevang Grove et al. · Thrombosis Research · 2017 · 14 citations

Thrombosis, Metabolic Syndrome, Hypertension +11

Effects of semaglutide and empagliflozin on oxygenation, vascular autoregulation, and central thickness of the retina in people with type 2 diabetes: A prespecified secondary analysis of a randomised clinical trial

Søren Gullaksen, Liv Vernstrøm, Steffen S. Sørensen et al. · Journal of Diabetes and its Complications · 2023 · 11 citations · Full text